Comparison of Two Electrosurgical Modes for Endoscopic Submucosal Dissection of Superficial Colorectal Neoplasms: A Prospective Randomized Study by Sugihara, Yuusaku et al.
E ndoscopic submucosal dissection (ESD) is one of the standard treatments for large gastrointestinal 
superficial neoplasms in Japan because of its high en 
bloc resection rate [1].  There have also been quite a few 
reports about ESD for colorectal neoplasms [2, 3].  
However,  colorectal ESD still has a few improvable 
technical issues.  One of these issues is the selection of 
the Endo-cut I mode versus the Swift-coagulation mode 
as the appropriate electrosurgical unit mode during 
submucosal dissection.
An electrosurgical unit has 2 basic electrocautery 
patterns: the cut current and the coagulation current.  
A cut current causes a more rapid increase in the target 
tissue temperature to > 100°C,  causing the cellular 
water to boil and the cells to rupture,  leading to cleav-
age of the tissue that lies along the electrode.  A coagu-
lation current causes a slower increase in temperature 
within cells (between 70°C and 100°C) and causes the 
cells to dehydrate and shrink without bursting.  The 
Endo-cut I mode is characterized by alternating a cut-
ting current and the lowest peak voltage coagulation 
current.  The continuous low voltage coagulation cur-
rent of < 200 peak voltage creates pure coagulation,  
which is called SOFT coagulation.
 Conversely,  a coagulation current is also able to 
create an incision effect when the current density is high 
and the contact area is narrow.  The Swift coagulation 
mode is characterized by a pulse modulated sine wave 
with 20% of the high voltage,  which allows both cutting 
and coagulation [4].  The Endo-cut I mode provides 
effective mucosal incision but has relatively low hemo-
static ability.  Conversely,  the Swift-coagulation mode is 
designed to enhance coagulation more than the Endo-
cut I mode.
To perform gastrointestinal ESD,  it has generally 
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been said that Swift-coagulation is suitable for the sub-
mucosal dissection phase because of the superiority of 
its hemostatic effect.  However,  the colorectum has 
fewer blood vessels than the esophagus.  The Endo-cut I 
mode provides high-performance submucosal dissec-
tion and mucosal cutting,  but its use is thought to 
increase the risk of bleeding and perforation in the col-
orectum where the wall is thinner than other gastroin-
testinal tracts.
Currently,  the electrosurgical unit mode used 
during submucosal dissection phase in colorectal ESD 
depends completely on the preference of the operator.  
We decided to select the two modes conventionally used 
at our institution.  There is no published report about 
which mode is more suitable; therefore,  there are no 
criteria for operators to use.  The aim of our planned 
study is to determine whether the Endo-cut I mode or 
the Swift-coagulation mode is more suitable for submu-
cosal layer dissection during colorectal ESD.
Endpoints
The primary outcome is the total procedure time of 
colorectal ESD.  The secondary outcomes are as fol-
lows: adverse events including perforation and postop-
erative bleeding,  the number of times a coagulation 
hemostat was used,  and the complete en bloc resection 
rate.  Adverse events will be prospectively evaluated 
from the patients’ records.  The number of times 
homeostatic forceps were used will be counted by 
reviewing the automatically recorded intraoperative 
video.  The en bloc resection rate and the complete resec-
tion rate will be evaluated after pathological examina-
tion.  For our study,  perforation will be deemed to have 
occurred when the ESD operator detects the perforation 
endoscopically during the ESD and the presence of free 
air is confirmed by abdominal X-ray by the morning 
following the ESD.  Postoperative bleeding will be 
deemed to have occurred if the patient notices hemato-
chezia within several hours after the ESD,  and if hemo-
stasis is required with emergency colonoscopy or the 
hemoglobin level is seen to have dropped by > 2 g/dl at 
the time of follow-up.
Eligibility Criteria
The patient inclusion criteria are: (1) tumor diag-
nosed with colonoscopy before ESD,  (2) lesions 20-50 mm 
in dia.,  (3) suspected lesions of colorectal intramucosal 
or slight-invasion (SM < 1000 μm) cancer,  and (4) sus-
pected lesion with no lymph node or distant metastasis 
before ESD.  The exclusion criteria are (1) non-correct-
able coagulopathy,  (2) severe organ failure,  (3) a 
comorbidity requiring continuous antithrombotic med-
ication,  (4) performance status > 2,  (5) age < 20 years,  
(6) no provision of informed consent,  and (7) the case 
is judged inappropriate by the chief medical examiner.
For this study,  the following criteria were set as the 
discontinuation criteria: (1) occurrence of serious 
adverse events (perforation,  major bleeding,  etc.),  
(2) a high possibility that a serious adverse event will 
occur as evaluated by the ESD operator,  and (3) diffi-
culty continuing ESD for other reasons.
Design and Study Setting
This study has been designed as a prospective,  ran-
domized controlled trial and will be conducted in the 
endoscopy unit of the Okayama University Graduate 
School of Medicine,  Japan between June 2018 and June 
2020.  The study has been registered in the University 
Hospital Medical Network Clinical Trials Registry 
(UMIN-CTR) as UMIN #000027638.
Ethics
The Institutional Review Board of Okayama 
University Hospital has approved this study.  The 
approval number is 1805-003.  We will obtain written 
informed consent from a parent or guardian of all of the 
subjects,  preoperatively.
Study Intervention
The study intervention protocol is illustrated in 
Fig. 1.  The study intervention will start after the 
patient’s colonoscopy screening in the division of 
endoscopy.  Subsequently,  we will discuss the thera-
peutic strategy for lesions,  including the above criteria,  
at the endoscopists’ conference.  The participants will be 
randomly assigned to treatment groups (Endo-cut I 
mode group and Swift-coagulation mode group) fol-
lowing simple randomization procedures.  The random-
ization table has been prepared using Excel 2007 
(Microsoft,  Redmond,  WA,  USA).  The endoscopists 
will be blinded to this allocation.  However,  when an 
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ESD is performed,  it is not feasible to blind the endos-
copist to the treatment allocation.
General Setting of the ESD
The ESD will be performed under intravenous seda-
tion using midazolam colonoscopy with a water jet 
function and a distal attachment cap (Olympus,  Tokyo) 
for all cases.  Tumor outlines will be delineated by chro-
moendoscopy with indigo carmine or narrow-band 
imaging.  Each ESD will be conducted using the Dual 
knife® (Olympus) only for mucosal incision and sub-
mucosal dissection.  As the tool used as a hemostat for-
ceps,  only the Coagrasper® (FD-410LR; Olympus) will 
be used.  As an electrosurgical unit,  we will use the 
VIO® 300D (Erbe,  Tübingen,  Germany) in all cases.  
Each knife is a dual knife with an Endo-cut I mode 
(Effect 1,  duration 3,  interval 3 for a marginal incision) 
and a Swift-coagulation mode (Effect 2,  35W).  The 
Coagrasper has a soft-coagulation mode (Effect 5 80W) 
for hemostasis.
The operator in this study will be the endoscopist at 
our institute who has performed approx.  60 cases of 
colonic and approx.  70 cases of stomach ESD.  All 
lesions will be resected using the same process,  as fol-
lows.  Step 1: A mucosal incision will be performed to 
make a flap to insert the colonoscope under the mucosa.  
Step 2: Submucosal dissection will be performed.
In this study,  when the knife reaches the submuco-
sal layer,  the dissection phase will proceed promptly in 
the assigned mode.  The time at which the mucosal 
incision phase ends and the submucosal dissection 
phase begins depends completely on the visual judg-
ment of the operator.  The total procedure time will be 
calculated by adding the time taken to perform Steps 1 
and 2.
Data Collection
Investigators will collect the following data: patient 
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(1) tumour  diagnosed with colonoscopy before ESD (2) lesions of 20-50 mm in diameter (3) colorectal intra-
mucosal or minutes-invaded (SM < 1000 μm) cancer (4) no lymph node or distant metastasis. 
Excluded  (1) non-correctable coagulopathy 
(2) severe organ failure 
(3) a comorbidity requiring con�nuous an�thrombo�c medica�on. 
Assessment of results
Post-treatment observation
Fig. 1 The patient ﬂow chart.  ESD: endoscopic submucosal dissection.
age,  body weight,  and gender; the pathological diag-
nosis of the tumor,  vital signs during colorectal ESD,  
peripheral blood general and biochemical examination 
results,  operation time,  and adverse events.
Statistical Considerations
The sample size has been calculated based on the 
initial results for colorectal ESD at our institution.  The 
mean procedure time for colorectal ESD is usually 
70 min using a dual knife.  We hypothesize that the pro-
cedure time using only the Endo-cut I mode will reduce 
the time by 15%,  i.e.,  approx.  60 min.  Therefore,  a 
total of 64 patients will be required in each group to 
detect a significant difference in a two-sided test with a 
significance level of 0.05 and a power of 80%.  The out-
comes of the present study,  such as the procedure time,  
will be expressed as the mean ± standard deviation.  
Continuous variables will be compared using Student’s 
t-test.  Categorical variables will be compared using the 
χ2-test or Fisher’s exact test,  as appropriate.  The signif-
icance level has been set at p < 0.05.  The statistical anal-
yses will be performed using the JMP 10.0 software 
package for Windows (SAS Institute,  Cary,  NC,  USA).
Discussion
To our knowledge,  this study is the first single-arm 
prospective interventional study to determine which 
mode of the electric system of the VIO 300D electro-
surgical unit is more appropriate for colorectal ESD.
A standard strategy for selecting the Endo-cut I 
mode or the Swift-coagulation mode for the dissection 
of the submucosal layer during colorectal ESD has not 
been established.  It is hoped that this trial will assist in 
the establishment of a standard strategy for colorectal 
ESD.  There has been no report regarding the selection 
of the electrical mode while performing ESD.  This 
study will present findings that will most likely prove to 
be a unique resource well into the future.
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